Suppr超能文献

4 周口服牛磺酸治疗肝硬化患者肌肉痉挛的疗效:一项单臂先导研究。

Effectiveness of 4-Week Oral Taurine Treatment for Muscle Cramps in Patients with Liver Cirrhosis: A Single-Arm Pilot Study.

机构信息

Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.

Department of Nursing, Suwon Science College, Hwaseong, Korea.

出版信息

Yonsei Med J. 2021 Jan;62(1):21-28. doi: 10.3349/ymj.2021.62.1.21.

Abstract

PURPOSE

Painful muscle cramps are a common complication in liver cirrhosis patients, and no effective treatment is available. This pilot study aimed to evaluate whether taurine supplementation improves muscle cramps in Korean cirrhotic patients.

MATERIALS AND METHODS

Ten cirrhotic patients who experienced muscle cramps one or more times/week were enrolled in this prospective single-arm study and administered with an oral taurine solution (1 g/50 mL) thrice a day for 4 weeks. Taurine was discontinued for the subsequent 4 weeks. The frequency and intensity of muscle cramps were evaluated using a questionnaire at weeks 0, 2, 4, 6, and 8 after the start of treatment.

RESULTS

At baseline, the median frequency of muscle cramps was six times/week, and all patients had severe pain. Muscle cramp scores (frequency×intensity) decreased in seven patients by weeks 4 and 8 after treatment initiation. Compared to baseline muscle cramp scores [median 21, interquartile range (IQR): 8-84], median muscle cramp scores were lower at week 4 (6.5, IQR: 3-12, =0.126) and week 8 (5, IQR: 1.5-56, =0.066). All five patients whose baseline plasma taurine levels were below the normal limit showed increased taurine levels at week 4; 60% of them experienced improvements in their muscle cramps. Of the five patients with normal or higher taurine levels, 80% experienced an improvement in symptoms at week 4. The safety and tolerability of the 4-week taurine therapy were excellent.

CONCLUSION

Oral taurine therapy for 4 weeks improved muscle cramps safely in cirrhotic patients.

摘要

目的

肌肉痉挛是肝硬化患者常见的并发症,但目前尚无有效的治疗方法。本研究旨在评估牛磺酸补充是否能改善韩国肝硬化患者的肌肉痉挛。

材料与方法

本前瞻性单臂研究纳入了 10 名每周出现 1 次或多次肌肉痉挛的肝硬化患者,给予口服牛磺酸溶液(1 g/50 mL),每日 3 次,持续 4 周。随后的 4 周停止牛磺酸治疗。在治疗开始后的第 0、2、4、6 和 8 周,使用问卷评估肌肉痉挛的频率和强度。

结果

在基线时,肌肉痉挛的中位数频率为每周 6 次,所有患者均有严重疼痛。7 名患者在治疗开始后第 4 周和第 8 周时肌肉痉挛评分(频率×强度)降低。与基线肌肉痉挛评分[中位数 21,四分位距(IQR):8-84]相比,第 4 周(6.5,IQR:3-12,=0.126)和第 8 周(5,IQR:1.5-56,=0.066)时的中位数肌肉痉挛评分更低。所有基线时血浆牛磺酸水平低于正常范围的 5 名患者在第 4 周时牛磺酸水平升高;60%的患者肌肉痉挛得到改善。在牛磺酸水平正常或更高的 5 名患者中,80%的患者在第 4 周时症状得到改善。4 周牛磺酸治疗的安全性和耐受性均良好。

结论

口服牛磺酸治疗 4 周可安全改善肝硬化患者的肌肉痉挛。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c5d/7820453/d1d473a07e0d/ymj-62-21-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验